Despite the broad economic difficulties facing the market, Q2 results proved favorable for Monsanto. Net sales increased 8% from the year-ago-period to $4,035 million and gross profits also saw 14% gains reaching $2,521 million. Because of increased sales of agricultural products (especially soybean and corn crops), earnings per share reached $2.96/share in the first half of 2009 compared to $2.48/share in the first half of 2008.
Monsanto has plans to invest heavily in the development of their biotechnology products. They are currently working to develop new innovations and to deliver multiple genetic benefits in one seed (called stacking). Consequently, R&D expenses increased almost 25% from the 6-months ended period from 2008.
Monsanto is expecting a period of high growth over the next three years with the launch of several high impact technology products (HITs). In a press conference on May 13, 2009, Kerry Preete, Monsanto Vice President, predicted that the company's gross profits would double from 2008 levels by the end of 2012.
Monsanto recently entered into collaborative efforts with BASF, a German based plant technology firm. The two companies are combining their biotechnological research in order to develop the world's first drought resistant corn seed. Projected launch of the product is 2012.
2010 © Better Trades | Contact Us